Codes / ICD10CM / T37.5X5A

T37.5X5A Adverse effect of antiviral drugs, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of antiviral drugs, initial encounter

Summary

This condition describes harmful or unintended reactions resulting from antiviral medication use, occurring during the initial encounter with the healthcare provider. It includes negative effects that are not part of the intended therapeutic action, such as allergic responses, organ toxicity, or other adverse events linked to antiviral agents.

Causes

Adverse effects may arise from allergic reactions, drug interactions, or individual sensitivity to antiviral medications. They can also result from incorrect dosing, formulation issues, or underlying patient factors that increase susceptibility to drug-related harm.

Risk Factors

  • Concurrent use of multiple medications increasing interaction risk.
  • Pre-existing renal or hepatic impairment affecting drug metabolism.
  • History of allergic reactions to antiviral or similar drug classes.
  • Age-related changes in drug clearance (e.g., pediatric or geriatric populations).
  • Genetic predispositions to drug hypersensitivity.

Symptoms

  • Gastrointestinal: Nausea, vomiting, diarrhea, or abdominal pain.
  • Dermatological: Rash, itching, or hypersensitivity reactions.
  • Neurological: Dizziness, confusion, headache, or seizures.
  • Hepatic: Elevated liver enzymes or jaundice.
  • Renal: Changes in urine output or kidney function abnormalities.

Diagnosis

Clinical evaluation based on patient history, medication use, and symptom presentation. Laboratory tests may assess drug levels, organ function, or specific markers of toxicity. Imaging or other studies are used as clinically indicated to evaluate affected systems.

Treatment Options

Management focuses on discontinuing the offending antiviral, providing supportive care, and addressing specific symptoms. This may include antihistamines for allergic reactions, antiemetics for gastrointestinal distress, or monitoring for organ dysfunction. In severe cases, specialized interventions like dialysis or antidotes may be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Most mild to moderate adverse effects resolve with discontinuation and supportive care. Follow-up may involve monitoring for recurrence, adjusting future medications, or referral to specialists if organ damage occurs.

Complications

Severe reactions can lead to organ failure, prolonged hospitalization, or permanent damage. Rarely, life-threatening events like anaphylaxis or toxic epidermal necrolysis may occur. Delayed recognition or treatment increases complication risk.

Lifestyle & Prevention

Patients should report new symptoms promptly and follow medication instructions carefully. Avoiding known allergens, using drug interaction checkers, and adhering to prescribed dosing can reduce risk. Healthcare providers should review medication lists regularly and educate patients on warning signs.

When to Seek Professional Help

Seek immediate care for severe symptoms like difficulty breathing, swelling, or altered mental status. Contact a provider for persistent or worsening reactions, even if mild, to prevent escalation.

Tips for Medical Coders

Document the specific antiviral agent involved, the nature of the adverse effect (e.g., allergic, toxic), and the encounter type (initial). Ensure clinical correlation between the medication and the reported reaction to support code assignment. Note any interventions or monitoring performed during the encounter.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T37.5X5A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.